{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:21:02Z","timestamp":1785223262728,"version":"3.55.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>The visual system is one of the most accessible routes to study the central nervous system under pathological conditions, such as in multiple sclerosis (MS). Non-invasive visual evoked potential (VEP) and optical coherence tomography (OCT) were used to assess visual function and neuroretinal thickness in C57BL\/6 taking 0.2% cuprizone for 7 weeks and at 5, 8, 12, and 15 days after returning to a normal diet. VEPs were significantly delayed starting from 4 weeks on cuprizone, with progressive recovery off cuprizone, becoming significant at day 8, complete at day 15. In contrast, OCT and neurofilament staining showed no significant axonal thinning. Optic nerve histology indicated that whilst there was significant myelin loss at 7 weeks on the cuprizone diet compared with healthy mice, at 15 days off cuprizone diet demyelination was significantly less severe. The number of Iba 1<jats:sup>+<\/jats:sup> cells was found increased in cuprizone mice at 7 weeks on and 15 days off cuprizone. The combined use of VEPs and OCT allowed us to characterize non-invasively, <jats:italic>in vivo<\/jats:italic>, the functional and structural changes associated with demyelination and remyelination in a preclinical model of MS. This approach contributes to the non-invasive study of possible effective treatments to promote remyelination in demyelinating pathologies.<\/jats:p>","DOI":"10.3389\/fnins.2022.820155","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T06:07:57Z","timestamp":1650002877000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Visual Evoked Potentials to Monitor Myelin Cuprizone-Induced Functional Changes"],"prefix":"10.3389","volume":"16","author":[{"given":"Silvia","family":"Marenna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Chun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Dalla Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"d\u2019Isa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Castoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Leocani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12974-017-0936-0","article-title":"Inflammatory demyelination alters subcortical visual circuits.","volume":"14","author":"Ara\u00fajo","year":"2017","journal-title":"J. Neuroinflammation."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e87736","DOI":"10.1371\/journal.pone.0087736","article-title":"Disruption of myelin leads to ectopic expression of K(V)1.1 channels with abnormal conductivity of optic nerve axons in a cuprizone-induced model of demyelination.","volume":"9","author":"Bagchi","year":"2014","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1152\/physrev.2001.81.2.871","article-title":"Biology of oligodendrocyte and myelin in the mammalian central nervous system.","volume":"81","author":"Baumann","year":"2001","journal-title":"Physiol. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1474-4422(16)30377-5","article-title":"Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial.","volume":"16","author":"Cadavid","year":"2017","journal-title":"Lancet Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/0041-008x(66)90062-7","article-title":"Response of mice to the chelating agents sodium diethyldithiocarbamate, alpha-benzoinoxime, and biscyclohexanone oxaldihydrazone.","volume":"8","author":"Carlton","year":"1966","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2018.02.015","article-title":"The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis.","volume":"318","author":"Chu","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/EB.S139417","article-title":"Retinal imaging with optical coherence tomography: A biomarker in multiple sclerosis?","volume":"10","author":"Costello","year":"2018","journal-title":"Eye Brain"},{"key":"B8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature12647","article-title":"A regenerative approach to the treatment of multiple sclerosis.","volume":"502","author":"Deshmukh","year":"2013","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/archneurol.2007.10","article-title":"Modeling axonal degeneration within the anterior visual system: implications for demonstrating neuroprotection in multiple sclerosis.","volume":"65","author":"Frohman","year":"2008","journal-title":"Arch. Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.brainres.2009.06.005","article-title":"Regional differences between grey and white matter in cuprizone induced demyelination.","volume":"1283","author":"Gudi","year":"2009","journal-title":"Brain Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"692599","DOI":"10.3389\/fnins.2021.692599","article-title":"Optical Coherence Tomography and Visual Evoked Potentials as Prognostic and Monitoring Tools in Progressive Multiple Sclerosis.","volume":"15","author":"Guerrieri","year":"2021","journal-title":"Front. Neurosci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jchemneu.2017.06.003","article-title":"Probenecid-treatment reduces demyelination induced by cuprizone feeding.","volume":"85","author":"Hainz","year":"2017","journal-title":"J. Chem. Neuroanat."},{"key":"B13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.brainresbull.2017.09.007","article-title":"The flavonoid Baicalein attenuates cuprizone-induced demyelination via suppression of neuroinflammation.","volume":"135","author":"Hashimoto","year":"2017","journal-title":"Brain Res. Bull."},{"key":"B14","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1365-2990.2011.01168.x","article-title":"Lack of cuprizone-induced demyelination in the murine spinal cord despite oligodendroglial alterations substantiates the concept of site-specific susceptibilities of the central nervous system.","volume":"37","author":"Herder","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/B978-012738761-1\/50002-X","author":"Hildebrand","year":"2005","journal-title":"The Structure of Myelinated Axons in the CNS, Multiple Sclerosis as A Neuronal Disease."},{"key":"B16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fnagi.2018.00278","article-title":"Age Influences Microglial Activation After Cuprizone-Induced Demyelination.","volume":"10","author":"Klein","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1005757","DOI":"10.1371\/journal.pcbi.1005757","article-title":"Dynamics and heterogeneity of brain damage in multiple sclerosis.","volume":"13","author":"Kotelnikova","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e12649","DOI":"10.1111\/jne.12649","article-title":"Changes in neurosteroidogenesis during demyelination and remyelination in cuprizone-treated mice.","volume":"30","author":"Leicaj","year":"2018","journal-title":"J. Neuroendocrinol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-52001-2.00028-5","author":"Leocani","year":"2014","journal-title":"Clinical Neurophysiology of Multiple Sclerosis. 1st edn, Handbook of Clinical Neurology. 1st edn."},{"key":"B20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10633-019-09680-z","article-title":"Semi-invasive and non-invasive recording of visual evoked potentials in mice.","volume":"138","author":"Marenna","year":"2019","journal-title":"Doc. Ophthalmol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2055217320963474","DOI":"10.1177\/2055217320963474","article-title":"Functional evolution of visual involvement in experimental autoimmune encephalomyelitis.","volume":"6","author":"Marenna","year":"2020","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"B22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","article-title":"The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system\u2019.","volume":"11","author":"Matsushima","year":"2001","journal-title":"Brain Pathol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1189\/jlb.3ri1116-494r","article-title":"Microglia-driven regulation of oligodendrocyte lineage cells, myelination, and remyelination\u2019.","volume":"101","author":"Miron","year":"2017","journal-title":"J. Leukocyte Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"101750","DOI":"10.1016\/j.jchemneu.2020.101750","article-title":"Protective impacts of erythropoietin on myelinization of oligodendrocytes and schwann cells in CNS and PNS following cuprizone-induced multiple sclerosis-histology, molecular, and functional studies.","volume":"104","author":"Mirzaie","year":"2020","journal-title":"J. Chem. Neuroanat."},{"key":"B25","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3892\/etm.2019.7654","article-title":"Effects of enhanced environment and induced depression on cuprizone mouse model of demyelination.","volume":"18","author":"Mohamed","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e1395","DOI":"10.1038\/cddis.2014.357","article-title":"Dock3 protects myelin in the cuprizone model for demyelination.","volume":"5","author":"Namekata","year":"2014","journal-title":"Cell Death Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1097\/NEN.0000000000000214","article-title":"Remyelination After Cuprizone-Induced Demyelination Is Accelerated in Juvenile Mice.","volume":"74","author":"Pfeifenbring","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1093\/brain\/awr022","article-title":"Class 3 semaphorins influence oligodendrocyte precursor recruitment and remyelination in adult central nervous system.","volume":"134","author":"Piaton","year":"2011","journal-title":"Brain"},{"key":"B29","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.neubiorev.2014.10.004","article-title":"Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis.","volume":"47","author":"Praet","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"5095","DOI":"10.1523\/JNEUROSCI.16-16-05095.1996","article-title":"Oligodendroglia regulate the regional expansion of axon caliber and local accumulation of neurofilaments during development independently of myelin formation.","volume":"16","author":"S\u00e1nchez","year":"1996","journal-title":"J. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1352458514538110","article-title":"Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria.","volume":"21","author":"Schippling","year":"2015","journal-title":"Mult. Scler."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/jnr.23918","article-title":"\u2018Preferential conduction block of myelinated axons by nitric axide\u2019.","volume":"95","author":"Shrager","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2008.070850","article-title":"Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.","volume":"172","author":"Skripuletz","year":"2008","journal-title":"Am. J. Pathol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1152\/physrev.00031.2018","article-title":"Myelin in the Central Nervous System: Structure.","volume":"99","author":"Stadelmann","year":"2019","journal-title":"Funct. Pathol. Physiol. Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e34823","DOI":"10.1371\/journal.pone.0034823","article-title":"The OSCAR-IB consensus criteria for retinal OCT quality assessment.","volume":"7","author":"Tewarie","year":"2012","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"22594","DOI":"10.1038\/s41598-021-01963-3","article-title":"Cuprizone feed formulation influences the extent of demyelinating disease pathology.","volume":"11","author":"Toomey","year":"2021","journal-title":"Sci. Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s11062-018-9724-4","article-title":"Neurotoxicity of Cuprizone in Female and Male Rats: Electrophysiological Observations.","volume":"50","author":"\u00dcnsal","year":"2018","journal-title":"Neurophysiology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e28770","DOI":"10.4161\/intv.28770","article-title":"Clinical applications of optical coherence tomography in urology.","volume":"3","author":"Wang","year":"2014","journal-title":"IntraVital"},{"key":"B39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13578-017-0181-3","article-title":"Strain differences in cuprizone induced demyelination.","volume":"7","author":"Yu","year":"2017","journal-title":"Cell Biosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"17995","DOI":"10.1038\/s41598-021-97590-z","article-title":"Development and validation of a novel HILIC method for the quantification of low-levels of cuprizone in cuprizone-containing chow.","volume":"11","author":"Zheng","year":"2021","journal-title":"Sci. Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3389\/fnins.2016.00613","article-title":"Electroacupuncture Promotes Remyelination after Cuprizone Treatment by Enhancing Myelin Debris Clearance.","volume":"10","author":"Zhu","year":"2017","journal-title":"Front. Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/glia.22511","article-title":"Alterations of juxtaparanodal domains in two rodent models of CNS demyelination.","volume":"61","author":"Zoupi","year":"2013","journal-title":"Glia"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.820155\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T06:07:59Z","timestamp":1650002879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.820155\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":42,"alternative-id":["10.3389\/fnins.2022.820155"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2022.820155","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,15]]},"article-number":"820155"}}